Published in Am J Obstet Gynecol on October 01, 1999
Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev (2012) 4.07
Comparison of two widely used PCR primer systems for detection of toxoplasma in amniotic fluid, blood, and tissues. J Clin Microbiol (2004) 1.17
Symptomatic toxoplasma infection due to congenital and postnatally acquired infection. Arch Dis Child (2006) 1.01
Comparison of four commercially available avidity tests for Toxoplasma gondii-specific IgG antibodies. Clin Vaccine Immunol (2012) 0.98
Congenital toxoplasmosis and prenatal care state programs. BMC Infect Dis (2014) 0.91
Performance of Polymerase Chain Reaction Analysis of the Amniotic Fluid of Pregnant Women for Diagnosis of Congenital Toxoplasmosis: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.87
Polymerase chain reaction in the diagnosis of congenital toxoplasmosis: more than two decades of development and evaluation. Parasitol Res (2011) 0.87
Reverse enzyme-linked immunosorbent assay using monoclonal antibodies against SAG1-related sequence, SAG2A, and p97 antigens from Toxoplasma gondii to detect specific immunoglobulin G (IgG), IgM, and IgA antibodies in human sera. Clin Vaccine Immunol (2008) 0.85
A meta analysis on risks of adverse pregnancy outcomes in Toxoplasma gondii infection. PLoS One (2014) 0.84
Preconception seroconversion and maternal seronegativity at delivery do not rule out the risk of congenital toxoplasmosis. Clin Diagn Lab Immunol (2002) 0.82
Toxoplasmosis during pregnancy: a case report and review of the literature. Hippokratia (2008) 0.81
Clinical value of specific immunoglobulin E detection by enzyme-linked immunosorbent assay in cases of acquired and congenital toxoplasmosis. J Clin Microbiol (2003) 0.80
Detection of acute toxoplasmosis in pigs using loop-mediated isothermal amplification and quantitative PCR. Korean J Parasitol (2013) 0.79
Prenatal and Early Postnatal Diagnosis of Congenital Toxoplasmosis in a Setting With No Systematic Screening in Pregnancy. Medicine (Baltimore) (2016) 0.75
Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies. Sex Transm Infect (2002) 4.14
Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis (1989) 3.67
Low male partner participation in antenatal HIV counselling and testing in northern Tanzania: implications for preventive programs. AIDS Care (2008) 3.58
Outbreak of necrotizing enterocolitis associated with Enterobacter sakazakii in powdered milk formula. J Clin Microbiol (2001) 2.62
Toxoplasmosis needs evaluation. An overview and proposals. Am J Dis Child (1989) 2.49
Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J Clin Microbiol (1997) 2.22
Uterine rupture after previous caesarean section. BJOG (2010) 2.18
Risk factors for Toxoplasma gondii infection in pregnancy. Results of a prospective case-control study in Norway. Am J Epidemiol (1996) 2.04
Prevalence and risk factors of severe obstetric haemorrhage. BJOG (2008) 1.97
Recombinant antigens to detect Toxoplasma gondii-specific immunoglobulin G and immunoglobulin M in human sera by enzyme immunoassay. J Clin Microbiol (2000) 1.92
Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol (1999) 1.92
CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut (2003) 1.87
Economic evaluation of maternal screening to prevent congenital syphilis. Sex Transm Dis (1984) 1.83
Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. Pediatrics (2001) 1.80
A novel immunoassay using recombinant allergens simplifies peanut allergy diagnosis. Int Arch Allergy Immunol (2010) 1.80
Acyclovir in late pregnancy to prevent neonatal herpes simplex. Lancet (1990) 1.71
Risk factors for sudden intrauterine unexplained death: epidemiologic characteristics of singleton cases in Oslo, Norway, 1986-1995. Am J Obstet Gynecol (2001) 1.69
Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators. J Am Coll Cardiol (1997) 1.67
Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines. Bone Marrow Transplant (2001) 1.66
Risk factors of HIV vertical transmission in a cohort of women under a PMTCT program at three peri-urban clinics in a resource-poor setting. J Perinatol (2010) 1.64
Detection of IgA specific for toxoplasmosis in serum and cerebrospinal fluid using a non-enzymatic IgA-capture assay. Diagn Immunol (1986) 1.60
The past and present role of the Sabin-Feldman dye test in the serodiagnosis of toxoplasmosis. Bull World Health Organ (1999) 1.56
Severe toxoplasmosis caused by a Toxoplasma gondii strain with a new isoenzyme type acquired in French Guyana. J Clin Microbiol (1998) 1.55
Real-time PCR for detection and quantitation of hepatitis B virus DNA. J Med Virol (2001) 1.52
Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G. J Pediatr (2000) 1.51
Variations in policies for management of the third stage of labour and the immediate management of postpartum haemorrhage in Europe. BJOG (2007) 1.51
Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol (1984) 1.47
Factors predicting interferon treatment response in patients with chronic hepatitis c: late viral clearance does not preclude a sustained response. Am J Gastroenterol (2001) 1.46
Hydroxyl radical generation in oxygen-treated infants. Pediatrics (1997) 1.46
Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol (2001) 1.44
The cytogenetic basis for classifying ependymomas. J Neuropathol Exp Neurol (1978) 1.44
Comparative epidemiology of sudden infant death syndrome and sudden intrauterine unexplained death. Arch Dis Child Fetal Neonatal Ed (2002) 1.43
A systematic review of the prevalence of Chlamydia trachomatis among European women. Hum Reprod Update (2002) 1.43
Rotavirus genotypes co-circulating in Europe between 2006 and 2009 as determined by EuroRotaNet, a pan-European collaborative strain surveillance network. Epidemiol Infect (2010) 1.42
Preoperative ECMO in congenital cyanotic heart disease using the AREC system. Ann Thorac Surg (1997) 1.41
Human parvoviruses B19, PARV4 and bocavirus in pediatric patients with allogeneic hematopoietic SCT. Bone Marrow Transplant (2013) 1.41
Type of delivery onset has a significant impact on post-natal mortality in preterm infants of less than 30 weeks' gestation. Acta Paediatr (2014) 1.38
Early neonatal diagnosis of congenital toxoplasmosis: value of comparative enzyme-linked immunofiltration assay immunological profiles and anti-Toxoplasma gondii immunoglobulin M (IgM) or IgA immunocapture and implications for postnatal therapeutic strategies. J Clin Microbiol (1996) 1.35
Real-time PCR targeting a 529-bp repeat element for diagnosis of toxoplasmosis. Clin Microbiol Infect (2006) 1.33
An enzyme-linked immuno-filtration assay used to compare infant and maternal antibody profiles in toxoplasmosis. J Immunol Methods (1985) 1.31
Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis Suppl (1992) 1.28
Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur J Clin Microbiol Infect Dis (2001) 1.26
HIV seroprevalence and its associations with the other reproductive tract infections in asymptomatic women in Harare, Zimbabwe. Int J STD AIDS (2001) 1.26
Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy. Sex Transm Infect (1999) 1.24
Ultrasensitive bioanalytical assays using time-resolved fluorescence detection. Pharmacol Ther (1995) 1.24
Provocative appeals in anti-smoking mass media campaigns targeting adolescents--the accumulated effect of multiple exposures. Health Educ Res (1997) 1.24
Evaluation of the possibilities for preventing congenital toxoplasmosis. Am J Perinatol (1994) 1.22
Eosinophilic differentiation of the human promyelocytic leukemia cell line, HL-60. J Exp Med (1984) 1.22
Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation. Br Heart J (1995) 1.21
Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group. Scand J Infect Dis (1998) 1.19
An anti-human mu chain monoclonal antibody: use for detection of IgM antibodies to Toxoplasma gondii by reverse immunosorbent assay. J Immunol Methods (1985) 1.18
Realities and Challenges of a Five Year Follow Up of Mother and Child Pairs on a PMTCT Program in Zimbabwe. Open AIDS J (2011) 1.18
Induction of a protective antibody-dependent response against toxoplasmosis by in vitro excreted/secreted antigens from tachyzoites of Toxoplasma gondii. Parasite Immunol (1988) 1.15
The program for antenatal screening of toxoplasmosis in Finland: a prospective cohort study. Scand J Infect Dis Suppl (1992) 1.13
Toxoplasmosis in pregnancy. Baillieres Clin Obstet Gynaecol (1993) 1.13
Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1. Allergy (2006) 1.12
Association between congenital toxoplasmosis and preterm birth, low birthweight and small for gestational age birth. BJOG (2005) 1.11
Prevalence of Toxoplasma gondii specific immunoglobulin G antibodies among pregnant women in Norway. Epidemiol Infect (1998) 1.10
Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol (1998) 1.10
Recent trends in research on congenital toxoplasmosis. Int J Parasitol (2001) 1.10
High prevalence and genotypes of Toxoplasma gondii isolated from goats, from a retail meat store, destined for human consumption in the USA. Int J Parasitol (2011) 1.09
Knowledge-based interpretation of toxoplasmosis serology test results including fuzzy temporal concepts--the ToxoNet system. Stud Health Technol Inform (2001) 1.09
Increased incidence of Mycoplasma pneumoniae infection in Finland, 2010-2011. Euro Surveill (2012) 1.09
Involvement of calcium and calmodulin in Toxoplasma gondii tachyzoite invasion. Eur J Cell Biol (1997) 1.08
Development of specific immunoglobulins G, M, and A following primary Toxoplasma gondii infection in pregnant women. J Clin Microbiol (1998) 1.08
A new europium chelate for protein labelling and time-resolved fluorometric applications. Clin Biochem (1988) 1.08
Quantitative immunolocalization of a P29 protein (GRA7), a new antigen of toxoplasma gondii. J Histochem Cytochem (1998) 1.08
Value of specific immunoglobulin A detection by two immunocapture assays in the diagnosis of toxoplasmosis. Eur J Clin Microbiol Infect Dis (1995) 1.08
Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France. Epidemiol Infect (2004) 1.08
Chronic Ureaplasma urealyticum amnionitis associated with abruptio placentae. Obstet Gynecol (1986) 1.07
Congenital toxoplasmosis: a prospective survey in Brussels. Br J Obstet Gynaecol (1984) 1.07
Genetic characterization of Toxoplasma gondii from wild boar (Sus scrofa) in France. Vet Parasitol (2009) 1.07
Rotavirus surveillance in europe, 2005-2008: web-enabled reporting and real-time analysis of genotyping and epidemiological data. J Infect Dis (2009) 1.06
Cesarean section among immigrants in Norway. Acta Obstet Gynecol Scand (2000) 1.06
Interlaboratory comparison of polymerase chain reaction for the detection of Toxoplasma gondii DNA added to samples of amniotic fluid. Eur J Clin Microbiol Infect Dis (1996) 1.06
Reactivity of (1→3)-β-d-glucan assay in bacterial bloodstream infections. Eur J Clin Microbiol Infect Dis (2011) 1.05
Association study of FUT2 (rs601338) with celiac disease and inflammatory bowel disease in the Finnish population. Tissue Antigens (2012) 1.05
Toxopert-I: knowledge-based automatic interpretation of serological tests for toxoplasmosis. Comput Methods Programs Biomed (1997) 1.05
Double-blind study of glaucine in chronic cough. Int J Clin Pharmacol Ther Toxicol (1981) 1.05
Prevalence and estimated incidence of Toxoplasma infection among pregnant women in Poland: a decreasing trend in the younger population. Clin Microbiol Infect (2006) 1.05
Safety evaluation of piperacillin/tazobactam in very low birth weight infants. J Chemother (2004) 1.04
Central venous catheter mechanical irritation of the right atrial free Wall:A cause for thrombus formation. Cardiology (1999) 1.02
Modified indirect immunofluorescence test for serotyping large numbers of Ureaplasma urealyticum clinical isolates. J Clin Microbiol (1987) 1.02
Time-resolved detection of lanthanide luminescence for ultrasensitive bioanalytical assays. J Photochem Photobiol B (1995) 1.02